A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000) (English)
- New search for: Delbaldo, C.
- New search for: Serin, D.
- New search for: Mousseau, M.
- New search for: Greget, S.
- New search for: Audhuy, B.
- New search for: Priou, F.
- New search for: Berdah, J.F.
- New search for: Teissier, E.
- New search for: Laplaige, P.
- New search for: Zelek, L.
- New search for: Delbaldo, C.
- New search for: Serin, D.
- New search for: Mousseau, M.
- New search for: Greget, S.
- New search for: Audhuy, B.
- New search for: Priou, F.
- New search for: Berdah, J.F.
- New search for: Teissier, E.
- New search for: Laplaige, P.
- New search for: Zelek, L.
In:
EUROPEAN JOURNAL OF CANCER -A-
;
50
, 1
;
23-30
;
2014
-
ISSN:
- Article (Journal) / Print
-
Title:A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)
-
Contributors:Delbaldo, C. ( author ) / Serin, D. ( author ) / Mousseau, M. ( author ) / Greget, S. ( author ) / Audhuy, B. ( author ) / Priou, F. ( author ) / Berdah, J.F. ( author ) / Teissier, E. ( author ) / Laplaige, P. ( author ) / Zelek, L. ( author )
-
Published in:EUROPEAN JOURNAL OF CANCER -A- ; 50, 1 ; 23-30
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam
-
Publication date:2014-01-01
-
Size:8 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.994
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.994 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 50, Issue 1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1.e1
-
EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectumvan de Velde, C. J. H. / Boelens, P. G. / Borras, J. M. / Coebergh, J. W. / Cervantes, A. / Blomqvist, L. / Beets-Tan, R. G. H. / van den Broek, C. B. M. / Brown, G. / Van Cutsem, E. et al. | 2014
- 23
-
A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)Delbaldo, C. / Serin, D. / Mousseau, M. / Greget, S. / Audhuy, B. / Priou, F. / Berdah, J.F. / Teissier, E. / Laplaige, P. / Zelek, L. et al. | 2014
- 31
-
Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - A population based study from the NetherlandsNederend, J. / Duijm, L. E. M. / Louwman, M. W. J. / Coebergh, J. W. / Roumen, R. M. H. / Lohle, P. N. / Roukema, J. A. / Rutten, M. J. C. M. / van Steenbergen, L. N. / Ernst, M. F. et al. | 2014
- 40
-
A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancerLange, A. / Prenzler, A. / Frank, M. / Kirstein, M. / Vogel, A. / von der Schulenburg, J.M. et al. | 2014
- 50
-
Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown originThomassen, I. / Verhoeven, R.H.A. / van Gestel, Y.R.B.M. / van de Wouw, A.J. / Lemmens, V.E.P.P. / de Hingh, I.H.J.T. et al. | 2014
- 57
-
FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancerLoupakis, F. / Cremolini, C. / Salvatore, L. / Masi, G. / Sensi, E. / Schirripa, M. / Michelucci, A. / Pfanner, E. / Brunetti, I. / Lupi, C. et al. | 2014
- 64
-
Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinomaJeon, H.G. / Choo, S.H. / Sung, H.H. / Jeong, B.C. / Seo, S.I. / Jeon, S.S. / Choi, H.-Y. / Lee, H.M. et al. | 2014
- 70
-
Adjuvant 5-flurouracil, alpha-interferon and interleukin-2 versus observation in patients at high risk of recurrence after nephrectomy for renal cell carcinoma: Results of a Phase III randomised European Organisation for Research and Treatment of Cancer (Genito-Urinary Cancers Group)/National Cancer Research Institute trialAitchison, M. / Bray, C.A. / Van Poppel, H. / Sylvester, R. / Graham, J. / Innes, C. / McMahon, L. / Vasey, P.A. et al. | 2014
- 78
-
Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abirateroneBianchini, D. / Lorente, D. / Rodriguez-Vida, A. / Omlin, A. / Pezaro, C. / Ferraldeschi, R. / Zivi, A. / Attard, G. / Chowdhury, S. / de Bono, J.S. et al. | 2014
- 85
-
Chromosomal gains and losses in human papillomavirus-associated neoplasia of the lower genital tract - A systematic review and meta-analysisThomas, L. K. / Bermejo, J. L. / Vinokurova, S. / Jensen, K. / Bierkens, M. / Steenbergen, R. / Bergmann, M. / von Knebel Doeberitz, M. / Reuschenbach, M. et al. | 2014
- 99
-
Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - A study of the OVCAD consortiumPils, D. / Bachmayr-Heyda, A. / Auer, K. / Svoboda, M. / Auner, V. / Hager, G. / Obermayr, E. / Reiner, A. / Reinthaller, A. / Speiser, P. et al. | 2014
- 111
-
The prognostic significance of sentinel node tumour burden in melanoma patients: An international, multicenter study of 1539 sentinel node-positive melanoma patientsvan der Ploeg, A. P. T. / van Akkooi, A. C. J. / Haydu, L. E. / Scolyer, R. A. / Murali, R. / Verhoef, C. / Thompson, J. F. / Eggermont, A. M. M. et al. | 2014
- 121
-
Efficacy and safety of ipilimumab 3 mg/kg in patients with pretreated, metastatic, mucosal melanomaDel Vecchio, M. / Di Guardo, L. / Ascierto, P.A. / Grimaldi, A.M. / Sileni, V.C. / Pigozzo, J. / Ferraresi, V. / Nuzzo, C. / Rinaldi, G. / Testori, A. et al. | 2014
- 128
-
Primary cardiac sarcomas: A retrospective study of the French Sarcoma GroupIsambert, N. / Ray-Coquard, I. / Italiano, A. / Rios, M. / Kerbrat, P. / Gauthier, M. / Blouet, A. / Chaigneau, L. / Duffaud, F. / Piperno-Neumann, S. et al. | 2014
- 137
-
Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenaseChoi, S. A. / Lee, J. Y. / Phi, J. H. / Wang, K. C. / Park, C. K. / Park, S. H. / Kim, S. K. et al. | 2014
- 150
-
Quantitative and qualitative analysis of study-related patient information sheets in randomised neuro-oncology phase III-trialsReinert, C. / Kremmler, L. / Burock, S. / Bogdahn, U. / Wick, W. / Gleiter, C. H. / Koller, M. / Hau, P. et al. | 2014
- 159
-
The NF-@kB pathway is rarely spontaneously activated in mantle cell lymphoma (MCL) cell lines and patient's samplesCamara-Clayette, V. / Lecluse, Y. / Schrader, C. / Klapper, W. / Vainchenker, W. / Hermine, O. / Ribrag, V. et al. | 2014
- 159
-
The NF- kappa B pathway is rarely spontaneously activated in mantle cell lymphoma (MCL) cell lines and patient's samplesCamara-Clayette, V. / Lecluse, Y. / Schrader, C. / Klapper, W. / Vainchenker, W. / Hermine, O. / Ribrag, V. et al. | 2014
- 170
-
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma studyDi Giannatale, A. / Dias-Gastellier, N. / Devos, A. / Mc Hugh, K. / Boubaker, A. / Courbon, F. / Verschuur, A. / Ducassoul, S. / Malekzadeh, K. / Casanova, M. et al. | 2014
- 178
-
Treatment and prognostic factors in pleuropulmonary blastoma: An EXPeRT reportBisogno, G. / Brennan, B. / Orbach, D. / Stachowicz-Stencel, T. / Cecchetto, G. / Indolfi, P. / Bien, E. / Ferrari, A. / Dommange-Romero, F. et al. | 2014
- 185
-
Variation in detection of ductal carcinoma in situ during screening mammography: A survey within the International Cancer Screening NetworkLynge, E. / Ponti, A. / James, T. / Majek, O. / von Euler-Chelpin, M. / Anttila, A. / Fitzpatrick, P. / Frigerio, A. / Kawai, M. / Scharpantgen, A. et al. | 2014
- 193
-
Non-linear dose-response relationship between cigarette smoking and pancreatic cancer risk: Evidence from a meta-analysis of 42 observational studiesZou, L. / Zhong, R. / Shen, N. / Chen, W. / Zhu, B. / Ke, J. / Lu, X. / Zhang, T. / Lou, J. / Wang, Z. et al. | 2014
- 193
-
Non-linear dose-response relationship between cigarette smoking and pancreatic cancer risk: Evidenc from a meta-analysis of 42 observational studiesZou, L. / Zhong, R. / Shen, N. / Chen, W. / Zhu, B. / Ke, J. / Lu, X. / Zhang, T. / Lou, J. / Wang, Z. et al. | 2014
- 204
-
Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic conditionKannan, A. / Krishnan, A. / Ali, M. / Subramaniam, S. / Halagowder, D. / Sivasithamparam, N.D. et al. | 2014
- 216
-
The multiple layers of non-genetic regulation of PTEN tumour suppressor activityCorreia, N.C. / Girio, A. / Antunes, I. / Martins, L.R. / Barata, J.T. et al. | 2014
- 226
-
Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylationMonteiro-Reis, S. / Leca, L. / Almeida, M. / Antunes, L. / Monteiro, P. / Dias, P.C. / Morais, A. / Oliveira, J. / Henrique, R. / Jeronimo, C. et al. | 2014
- 234
-
DNA vaccination against membrane-bound Kit ligand: A new approach to inhibiting tumour growth and angiogenesisOlgasi, C. / Dentelli, P. / Rosso, A. / Iavello, A. / Togliatto, G. / Toto, V. / Liberatore, M. / Barutello, G. / Musiani, P. / Cavallo, F. et al. | 2014
- 247
-
Talc used in anticancer drugs is promoter for diabetes in hepatocellular carcinoma induced ratsSingh, R. / Afzal, M. / Kazmi, I. / Anwar, F. et al. | 2014